Isotonix Essentials™舒寧營養沖飲 - 單盒裝(30包)

HK$574.00 HKD
HK$11.48 HKD 現金回贈

此產品符合減免運費。 產品詳細資料

產品資訊

益處


  • 有助改善並穩定情緒
  • 可促進平靜與放鬆
  • 支援健康的睡眠品質
  • 促進睡眠
  • 協助釋放精神緊張
  • 有助頭腦清晰
  • 有助正常的酵素調節
  • 促進認知健康
  • 提供抗氧化保護
  • 不含麩質、小麥、大豆、酵母、人造調味料、鹽、防腐劑或奶類

產品分類


不含麩質 - 本產品不含可檢測出之麩質*

不含可檢測出之基改成分(GMO) - 本產品不含可檢測出之基因改造生物成分

素食品 - 本產品為素食產品

等滲壓沖飲 - 易於飲用的液状營養補充品 / 健康食品,透過等滲壓狀態達致更佳的營養吸收

* 美國食品藥物監督管理局(FDA)將含有少於20PPM麩質的製成產品列為不含麩質

詳細資料


生活難免感到失衡與挫敗,特別是心情低落時突然來襲的煩躁與憂慮情緒。有時候你只需要將自己暫時從忙碌的生活壓力與繁瑣的思緒中解脫出來,享受片刻安寧。Isotonix Essentials系列產品為你的生活帶來一些平靜。

Isotonix Essentials舒寧營養沖飲專為放鬆精神而設,含有特殊配製的多種維他命、氨基酸與礦物質等成分,並採用便於使用的獨立包裝。配方所含的主要成分有助於安撫身體,促進思緒清晰,舒緩精神緊張,並且支援健康的睡眠品質。

將生活節奏放慢些,許多人都會從中受益。根據美國壓力管理學院(American Institute of Stress)統計,因為壓力,77%的人經常感到身體不適(例如:疲勞、頭痛、肌肉緊繃);76%的人經常遇到心理問題(例如:易怒、缺乏活力、感到緊張);而48%的人因此導致夜間失眠。值得注意的是,壓力的主要原因來自工作、金錢、健康、人際關係、營養不良、過多媒體資訊以及睡眠不足。

Isotonix Essentials 舒寧營養沖飲讓你神清氣爽,釋放一天的壓力!它有助提升並穩定情緒,促進思緒清晰並支援健康的睡眠品質。

資料來源:https://www.stress.org/daily-life

成分


左旋色胺酸:500毫克
在人體內,色胺酸會被轉換為5-羥色胺酸,進而被轉換為血清素。人體自身不能製造此種胺基酸,因此必須透過飲食或營養補充品補充。色胺酸存在於很多動物和植物蛋白中,含有色胺酸的食物包括奶製品、牛肉、家禽、大麥、糙米、魚類、大豆及花生。

維他命C(抗壞血酸):604毫克 
維他命C存在於椒類(甜椒、青椒、紅椒、紅辣椒及青辣椒)、柑橘類水果、結球甘藍、椰菜花、高麗菜、羽衣甘藍、芥蘭、芥菜、綠花菜、菠菜、番石榴、奇異果、黑醋栗及士多啤梨等。堅果類及穀類亦含有少量的維他命C。重要的是,在烹煮過程會破壞維他命C的活性。
維他命C支援健康的免疫系統,促進心血管健康,並且提供抗氧化功能。人體無法自行製造及儲存維他命C。因此,維他命C必須透過飲食和營養補充品而取得。

鉀 (碳酸氫鈉):384 毫克
鉀是儲存在肌肉中的電解質。富含鉀的食物包括香蕉、橙、哈蜜瓜、牛油果、生菠菜、高麗菜和芹菜。鉀是必要的巨量礦物質,能有助維持體液平衡,同時促進各種生化和生理過程。鉀支援正常的神經脈衝傳遞,心臟、骨骼肌及平滑肌的收縮,合成核酸,維持細胞內張力 在1928年,首次有人提出攝取大量的鉀可以有助維持心血管健康。鉀支援正常的肌肉放鬆以,同時促進肝糖和蛋白質的合成,是促進正常心跳的電解質。鉀支援人體調節水平衡的能力、運動後的恢復及人體廢物之排除。

鈣(乳酸鈣、碳酸鈣、硫酸鈣、檸檬酸鈣):375毫克
牛奶含有最高濃度的鈣質。其他富含鈣質的食物包括羽衣甘藍、大白菜、芥菜、西蘭花、白菜及豆腐。鈣質是重要的礦物質,具有多項生化功能。鈣質主要以氫氧基磷灰石的形式,Ca10 (PO4)6 (OH)2,存在於骨骼之中。

羥磷灰石約佔骨骼整體重量的40%。骨骼發育需要補充鈣質,而且骨骼也是鈣質的儲藏室。鈣質除了是骨骼與牙齒的主要成分外,也能支援正常的肌肉收縮、神經健康、心跳規律、血液凝結、能量產生及免疫系統功能。

每天補充足夠的鈣質,對於維持骨骼密度及健康的骨骼與牙齒是必要的,經證實也能緩解女性經前症候群的不適。若沒有每日攝取足夠的鈣質,身體會從骨骼中吸取鈣質,進而造成骨質流失。

血液中鈣質的含量是由PTH(副甲狀腺荷爾蒙)調節。體內高水平的鈣質與正常的心血管健康相關。美國糖尿病協會期刊(American Dietetic Association Journal)的研究指出,鈣有助中年婦女維持健康的體重。

鎂(碳酸鎂、檸檬酸鎂、甘胺酸鎂、氧化鎂):300毫克
鎂是骨骼礦化的元素之一,促進成人體內鉀和鈣的正常代謝,有助維持體內鉀、磷及鈣的含量於正常水平。鎂也能促進鈣的正常移動,將它運送到細胞內進一步運用,在肌肉和神經組織的正常運作上也扮演重要的角色。鎂同時有助於合成所有的蛋白質、核酸、核苷酸、環磷酸腺苷、脂肪以及碳水化合物。

鎂與鈣一同產生作用,維持正常的心臟功能。鎂同時也是健康的骨骼和牙齒所不可或缺,並有助健康的肌肉發育。鎂、鈣及維他命D三者共同維持骨骼健康。鎂維持正常的血小板功能,因此有助促進健康的心血管功能。

菸鹼酸(菸鹼醯胺):20菸鹼素總量毫克
菸鹼酸作為輔酵素(NAPH/ NADPH) ,在200種酵素中發揮重要作用,能促進正常的組織呼吸、脂肪酸的合成、碳水化合物與氨基酸的代謝、以及氫的傳輸。菸鹼酸濃度過低時,身體可以運用左旋色胺酸製造維他命。身體需要60毫克的左旋色胺酸才能產生1毫克的菸鹼酸,這個過程會快速減少左旋色胺酸含量。當體內有足夠的菸鹼酸時,左旋色胺酸便可用在其他地方,例如維持健康的血清素濃度。

維他命B6(鹽酸吡哆醇):4毫克
維他命B6促進正常的神經脈衝傳導,葡萄糖的肝醣分解,原血紅素合成,以及胺基酸與神經傳導物質的合成/代謝。維他命B6在轉換為磷酸吡哆醛(PLP)之後,可作為許多酵素反應的輔因子,參與左旋色胺酸活動,包括將左旋色胺酸轉換為血清素。

核黃素(維他命B2):2.9毫克
維他命B2存在於肝臟、奶製品、深綠色蔬菜和某些種類的海鮮。它是一種輔酵素,和其他的維他命B產生作用。維他命B2促進健康的紅血球形成、支援神經系統、呼吸、抗體產生及人類正常的生長。維他命B2支援健康肌膚、指甲及頭髮生長。維他命B2支援身體將食物轉換為能量的能力,是電子傳遞鏈的一部分,能給予細胞能量。核黃素可用於孕婦或哺乳期婦女,以及熱量需求高的運動員。維他命也能促進正常的脂肪分解。維他命B2為水溶性,除非攝取相當大的分量,否則無法儲存於人體內,因此必須每日補充。

錳(硫酸錳):5毫克
錳是一種在植物和動物裡大量存在的礦物質。最重要的飲食來源包含全穀類、堅果、葉菜和茶。錳大量存在於穀糠,但穀糠常在加工過程中去除。

人體組織內僅含有微量的錳。錳主要儲存於骨骼、肝臟、腎臟和胰腺,有助維護結締組織、骨骼、凝血因子的正常功能。它同時促進正常脂肪和碳水化合物的代謝,有助鈣質吸收,有助維護正常的大腦及神經功能。

錳是抗氧化酵素-錳超氧化物歧化酶(MnSOD)-的組成部分。抗氧化物可清除人體內天然產生的自由基,但此過程可能造成老化。如錳超氧化物歧化酶(MnSOD)的抗氧化物能夠中和自由基。

專家估計,37%的美國人並未從他們的日常飲食中攝足建議的每日錳攝取量,這可能是因為許多美國人食用精製的穀類食物多於全穀類食物,而全穀類食物卻是錳主要的膳食來源。相較於全穀類食物,精製的穀類食物只能提供一半份量的錳。

硼(檸檬酸硼):5毫克
礦物質硼主要來源為植物性食物如水果乾、堅果、深綠色葉菜、蘋果醬、葡萄汁及經煮過的乾豆類。硼存在於大部分的身體組織中,但主要分佈在骨骼、脾臟與甲狀腺。硼有助骨骼生長,支援身體的建構能力,維持健康的骨骼,也能有助留住足夠的鈣與鎂,促進適當的骨骼礦化。硼是將維他命D轉化成活性成分的必要輔因子。有助維持健康的細胞膜、支援適當的心智功能與警覺性、以及維持游離鈣濃度。

維他命D3 (膽鈣化醇):12.5 微克(500 國際單位)
大多數人類獲得維他命D的主要途徑是規律的日曬。維他命D的飲食來源包括維他命D強化牛奶(每杯含100國際單位)、鱈魚肝油及富含脂肪的魚類(例如三文魚),也少量存在於蛋黃與肝臟中。

維他命D促進鈣質和磷的吸收,並支援幾種參與鈣吸收和儲存的蛋白質的產生。維他命D與鈣兩者共同促進骨骼強壯。維他命D有助將造骨細胞中的鈣質運送至細胞外液和腎臟,也能促進腎小管與腸上皮對鈣與磷的再吸收,支援正常的皮膚細胞生長。

維他命A(1%的β-胡蘿蔔素):362微克視黃醇活性當量RAE
維他命A是脂溶性維他命,來源包括動物內臟(如肝臟和腎臟)、蛋黃、牛油、紅蘿蔔汁、南瓜、番薯、菠菜、桃子、強化奶製品和鱈魚肝油。維他命A是視黃醇、視黃醛和β-胡蘿蔔素等複合物家族的成員。維他命A提供全身組織的正常發育及修護。

常見問答


Isotonix® 代表甚麼?
Isotonix等滲透營養補充品透過等滲透液傳遞,即是說,人體花很少工夫就能達到最高效的營養吸收。等滲透懸浮液使營養素能直達小腸,並快速被血液所吸收。Isotonix產品的營養流失量微乎其微,帶來極有效率的吸收,提供最佳效果。

誰應使用此產品?
任何尋求休息與放鬆的人,以及因壓力(例如旅行、工作、家庭)導致睡眠不良而希望尋求解決方法的人。

我應如何使用Isotonix Essentials 舒寧營養沖飲?
把包裝內的粉末倒進杯子,加入8盎司(240毫升)的水並攪拌後飲用。空肚飲用效果最佳。

我多久應使用一次 Isotonix Essentials 舒寧營養沖飲?
作為營養補充品,每日飲用一次,或按你的醫護人員的指示飲用。

我應該在甚麼時候使用Isotonix Essentials 舒寧營養沖飲?
當你希望減壓及放鬆的時候,即可使用。

Isotonix Essentials舒寧營養沖飲與其他市場上同類型的營養產品有甚麼分別?
Isotonix Essentials舒寧營養沖飲明白你需要神清氣爽的感覺,因此我們提供含有礦物質及氨基酸的營養產品來支援你的休息及放鬆。它有助提升並穩定情緒,促進思緒清晰並支援健康的睡眠品質。

本產品有哪些注意事項?
如果你正在服用任何處方藥物或患有長期疾病,請在飲用本品前先向醫護人員諮詢。鎂會增加患上高鎂血症風險,有腎功能問題的患者應謹慎使用。如果出現腹瀉、腹部痙攣或不適,請停止使用本產品並諮詢你的醫護人員。如果你正在服用任何助眠劑、單胺氧化酶抑製劑(MAOI)或其他抗抑鬱藥如Zoloft或Paxil,以及精神藥物或鎮靜藥物如Klonopin或Valium,或止痛藥如Demerol或Ultram,請在使用本產品前先向醫護人員諮詢。請將此補充劑與其他處方藥物分開使用。懷孕或哺乳期婦女不宜使用本產品。

Isotonix Essentials 舒寧營養沖飲安全嗎?
此產品安全且不含有害物質、防腐劑及酒精。本產品在美國製造,並經美國食品及藥物管理局檢測設備生產,符合生產規範。顧客對本產品的質量和安全可絕對有信心。

科學


  • aan het Rot, M., et al. Social behaviour and mood in everyday life: the effects of tryptophan in quarrelsome individuals. Journal of Psychiatry and Neuroscience. 31(4): 253-262, 2006.
  • Allender PS, Cutler JA, Follman D, et al. Dietary calcium and blood pressure: meta—analysis of randomized clinical trials. Ann Intern Med. 1996; 124:825-831. 
  • Altura BM and Altura BT. Magnesium and cardiovascular biology: An important link between cardiovascular risk factors and atherogenesis. Cell Mol Biol Res. 41:347-59, 1995.
  • Altura BM, Altura BT. Role of magnesium and calcium in alcohol-induced hypertension and strokes as probed by in vivo television microscopy, digital image microscopy, optical spectroscopy, 31P-NMR, spectroscopy and a unique magnesium ion-selective electrode. Alcohol Clin Exp Res. 1994; 18:1057-1068. 
  • Appel LJ. Nonpharmacologic therapies that reduce blood pressure: A fresh perspective. Clin Cardiol. 22:1111-5, 1999.
  • Baly DL, Schneiderman JS, Garcia-Welsh AL. Effect of manganese deficiency on insulin binding, glucose transport and metabolism in rat adipocytes. J Nutr. 1990; 120:1075-1079. 
  • Barker J. Insomnia options; natural medicine choices. Townsend Letter for Doctors and Patients. April 2004.
  • Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. N Engl J Med 1999;340:101-107. 
  • Baron JA, Tosteson TD, Wargovich MJ, et al. Calcium supplementation and rectal mucosal proliferation: a randomized controlled trial. J Natl Cancer Inst 1995;87:1303-1307. 
  • Baxter GF, Sumeray MS, Walker JM. Infant size and magnesium: insights into LIMIT-2 and ISIS-4 from experimental studies. Lancet. 1996; 348:1424-1426. 
  • Beattie JH, Peace HS. The influence of a low-boron diet and boron supplementation on bone, major mineral and sex steroid metabolism in postmenopausal women. Br J Nutr. 1993 May;69(3):871-84. 
  • Bell , C., et al. Tryptophan depletion and its implications for psychiatry. British Journal of Psychiatry. 178: 399-405, 2001.
  • Bell L, Halstenson CE, Halstenson CJ, et al. Cholesterol-lowering effects of calcium carbonate in patients with mild to moderate hypercholesterolemia. Arch Intern Med. 1992; 152:2441-2444.
  • Bilbey, D.L. J., et al. Muscle cramps and magnesium deficiency: case reports. Can Fam Physician. 42:1348-51, 1996.
  • Booij, L., et al. Acute tryptophan depletion as a model of depressive relapse. British Journal of Psychiatry. 187: 148-154, 2005.
  • Bostick RM, Kushi LH, Wu Y, et al. Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol 1999;149:151-160. 
  • Brilla, L. R., et al. Effect of magnesium supplementation on strength training in humans. J Am Coll Nutr. 11(3):326-329, 1992.
  • Britton J, Pavord I, Richards K, et al. Dietary magnesium, lung function, wheezing, and airway hyper-reactivity in a random adult population sample. Lancet. 1994; 344:357-362. 
  • Brown R. and Gerbarg P. Herbs and nutrients in the treatment of depression, anxiety, insomnia, migraine, and obesity. J Psychiatr Pract. 7(2):75-91, 2001.
  • Buckley LM, Leib ES, Cartularo KS, et al. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. Ann Intern Med. 1996; 125:961-968. 
  • Caddell JL. Magnesium deficiency promotes muscle weakness, contributing to the risk of sudden infant death (SIDS) in infants sleeping prone. Magnes Res. 14(1-2):39-50, 2001. Review.
  • Casscells W. Magnesium and myocardial infarction. Lancet. 1994; 343:807-809. 
  • Chollet D et al. Blood and brain magnesium in inbred mice and their correlation with sleep quality. Am J Physiol Regul Integr Comp Physiol. 279(6):R2173-8, 2000.
  • Christiansen CW, Rieder MA, Silverstein EL, Gencheff NE. Magnesium sulfate reduces myocardial infarct size when administered before but not after coronary reperfusion in a canine model. Circulation. 1995; 92:2617-2621. 
  • Christin Marandino, Vegetarian Times, August 1998 Curhan GC, Willett WC, Speizer FE, et al. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk of kidney stones in women. Ann Intern Med. 1997; 126:497-504. 
  • Cools, R., et al. Tryptophan depletion disrupts the motivational guidance of goal-directed behavior as a function of trait impulsivity. Neuropsychopharmacology. 30:1362-1373, 2005.
  • Corsonello A et al. Serum magnesium levels and cognitive impairment in hospitalized hypertensive patients. Magnes Res. 14(4):273-82, 2001.
  • Dahle, L. O., et al. The effect of oral magnesium substitution on pregnancy-induced leg cramps. Am J Obstet Gynecol. 173(1):175-180, 1995.
  • Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density on men and women 65 years of age and older. N Engl J Med. 1997; 337:670-676. 
  • de Lourdes Lima M, Cruz T, Carreiro Pousada J, et al. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care. 1998; 21:682-686. 
  • Del-Ben, C., et al. Serotonergic modulation of face-emotion recognition. Brazilian Journal of Medical and Biological Research. 41(4): 263-269, 2008.
  • Demirkaya S et al. A comparative study of magnesium, flunarizine and amitriptyline in the prophylaxis of migraine. J Headache Pain. 1:179-86, 2000.
  • Dietary Reference Intakes for Calcium, Phosphorous, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academy Press; 1997. 
  • Durlach J, Durlach V, Bac P, et al. Magnesium and therapeutics. Magnes Res. 1994; 7:313-328. 
  • Elisaf M, Merkouropoulos M, Tsianos EV. Siamopoulos KC. Pathogenetic mechanisms of hypomagnesemia in alcoholic patients. J Trace Elem Med Biol. 1995; 9:210-214. 
  • Elisaf M, Milionis H, Siamopoulos K. Hypomagnesemic hypokalemia and hypocalcemia: Clinical and laboratory characteristics. Mineral Electrolyte Metab. 23:105-12, 1997.
  • Facchinetti F, Borella P, Sances G, et al. Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol. 1991; 78:177-181. 
  • Garland CF, Garland FC, Gorham ED. Calcium and vitamin D. Their potential roles in colon and breast cancer prevention. Ann NY Acad Sci. 1999; 889:107-119. 
  • Gong H, Amemiya T. Optic nerve changes in manganese-deficient rats. Exp Eye Res. 1999; 68:313-320. 
  • Griffiths , W., et al. Tryptophan and sleep in young adults. Psychophysiology. 9(3): 345-356, 1972.
  • Gruber H et al. Magnesium deficiency: effect on bone mineral density in the mouse appendicular skeleton. BMC Musculoskelet Disord. 4(1):7, 2003.
  • Gullestad L, Dolva LO, Soyland E, et al. Oral magnesium supplementation improves metabolic variables and muscle strength in alcoholics. Alcohol Clin Exp Res. 1992; 16:986-990. 
  • Guran T et al. Cognitive and psychosocial development in children with familial hypomagnesaemia. Magnes Res. 24(1):7-12, 2011.
  • Hartmann, E. and Spinweber, C. Sleep induced by L-tryptophan. Effect of dosages within the normal dietary intake. The Journal of Nervous and Mental Disease. 167(8): 497-499, 1979.
  • Health & Medicine. (Statistical Data Included) American Fitness, July, 1999 Tannen RL. Effects of potassium on blood pressure control. Ann Intern Med. 1983; 98(part 2):773-780. 
  • Heaney RP. Calcium, dairy products and osteoporosis. J Am Coll Nutr. 2000; 19(2 Suppl):83S-99S. 
  • Hornyak M et al. Magnesium therapy for periodic leg movements-related insomnia and restless legs syndrome: an open pilot study. Sleep. 21:501-5, 1998.
  • Houston M. The role of magnesium in hypertension and cardiovascular disease. J Clin Hypertens (Greenwich). 13(11):843-7, 2011. Review.
  • Huerta MG, Roemmich JN, Kington ML, et al. Magnesium deficiency is associated with insulin resistance in obese children. Diabetes Care. 28:1175-81, 2005.
  • Huskisson E et al. The influence of micronutrients on cognitive function and performance. J Int Med Res. 35(1):1-19, 2007. Review.
  • Hussain S, Ali SF. Manganese scavenges superoxide and hydroxyl radicals: an in vitro study in rats. Neuroscience Letters. 1999; 261:21-24. 
  • Inna Slutsky et al. Enhancement of Learning and Memory by Elevating Brain Magnesium. Neuron. 65(2):165-77, 2010.
  • Institute of Medicine. Food and Nutrition Board. Dietary Reference Intakes: Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride. National Academy Press. Washington, DC, 1999.
  • ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulfate in 58,050 patients with suspected acute myocardial infarction. Lancet. 1995; 345:669-685. 
  • Jee SH et al. The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertens. 15:691-6, 2002.
  • Jorde R, Sundsfjord J, Haug E, et al. Relation between low calcium intake, parathyroid hormone, and blood pressure. Hypertension 2000;35:1154-1159. 
  • Kao WHL, Folsom AR, Nieto J, et al. Serum and dietary magnesium and the risk for type 2 diabetes mellitus (editorial). Arch. Int Med. 1999; 159:2151-2159. 
  • Keen CL, Ensunsa JL, Watson MH, et al. Nutritional aspects of manganese from experimental studies. Neurotoxicol. 1999; 20:213-223. 
  • Khosh, F. Natural approach to hypertension. Alternative Medicine Review. 6(6), 2001.
  • Kobrin SM and Goldfarb S. Magnesium Deficiency. Semin Nephrol. 10:525-35, 1990.
  • Krieger D, Krieger S, Jansen O, et al. Manganese and chronic hepatic encephalopathy. Lancet. 1995; 346:270-274. 
  • LeMarquand, D., et al. Behavioral disinhibition induced by tryptophan depletion in nonalcoholic young men with multigenerational family histories of paternal alcoholism. American Journal of Psychiatry. 156: 1771-1779, 1999.
  • Lim R, Herzog WR. Magnesium for cardiac patients: is it a valuable treatment supplement? Contemp Int Med. 1998; 10:6-9. 
  • Lipkin M, Newmark H. Effect of added dietary calcium on colonic epithelial-cell proliferation in subjects at high risk for familial colonic cancer. N Engl J Med. 1985; 313:1381-1384. 
  • Lopez-Ridaura R et al. Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care. 27:134-40, 2004.
  • Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med. 1995; 333:201-205. 
  • Maizels, M., et al. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache. 44(9):885-90, 2004.
  • Martini LA. Magnesium supplementation and bone turnover. Nutr Rev. 1999; 57:227-229. 
  • Mauskop A, Altura BM. Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci. 1998; 5:24-27. 
  • Mauskop, A., et al. Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci. 5(1):24-27, 1998.
  • Meyer KA et al. Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am J Clin Nutr. 71:921-30, 2000.
  • Monograph. L-Tryptophan. Alternative Medicine Review. 11(1): 52-56, 2006.
  • Murphy, S., et al. Tryptophan supplementation induces a positive bias in the processing of emotional material in healthy female volunteers. Psychopharmacology ( Berlin ). 187(1): 121-130, 2006.
  • Naghii MR, Wall PM, Samman S. The boron content of selected foods and the estimation of its daily intake among free-living subjects. J Am Coll Nutr. 1996 Dec;15(6):614-9. 
  • Neumeister, A., et al. Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy. Archives of General Psychiatry. 55: 524-530, 1998.
  • New SA et al. Nutritional influences on bone mineral density: a cross-sectional study in premenopausal women. Am J Clin Nutr. 65:1831-9, 1997.
  • Newnham RE. Essentiality of boron for healthy bones and joints. Environ Health Perspect. 1994;102:83-85 
  • Nielsen FH. Studies on the relationship between boron and magnesium which possibly affects the formation and maintenance of bones. Magnes Trace Elem. 1990;9:61-69 
  • Nielsen FH. Ultratrace minerals. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease, 9th ed. Baltimore, MD: Williams and Wilkins; 1999:283-303. 
  • Oginni LM, Sharp CA, Worsfold M, et al. Healing of rickets after calcium supplementation. Lancet. 1999; 353:296-297. 
  • Orchard TJ. Magnesium and type 2 diabetes mellitus (editorial). Arch Int Med. 1999; 159:2119-2120. 
  • Paolisso G et al. Daily magnesium supplements improve glucose handling in elderly subjects. Am J Clin Nutr. 55:1161-7, 1992.
  • Paolisso G, Sgamabato S, Pizza G, et al. Improved insulin response and action by chronic magnesium administration in aged NIDDM. Diabetes Care. 1989; 12:265-269. 
  • Peacock JM et al. Relationship of serum and dietary magnesium to incident hypertension: the Atherosclerosis Risk in Communities (ARIC) Study. Annals of Epidemiology. 9:159-65, 1999.
  • Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia. 1996; 16:257-263. 
  • Penland J.G. The importance of boron nutrition for brain and psychological function. Biol Trace Elem Res. 1998; 66:299-317.
  • Popoviciu L et al. Clinical, EEG, electromyographic and polysomnographic studies in restless legs syndrome caused by magnesium deficiency (abstract). Rom J Neurol Psychiatry. 31:55-61, 1993.
  • Preuss HG, Gondal JA, Lieberman S. Association of macronutrients and energy intake withhypertension. J Am Coll Nutr. 15:21-35, 1996.
  • Recker RR. Calcium absorption and achlorhydria. N Engl J Med. 1985; 313:70-73. 
  • Reid IR, Ames RW, Evans MC, et al. Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J Med. 1993; 328:460-464. 
  • Rivlin RS. Magnesium deficiency and alcohol intake: mechanisms, clinical significance and possible relation to cancer development (a review). J Am Coll Nutr. 1994; 13:416-423. 
  • Roberts JM. Magnesium for preeclampsia and eclampsia. N Engl J Med. 1995; 333:250-251. 
  • Rodriguez-Moran M and Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects. Diabetes Care. 26:1147-52, 2003.
  • Roffe C, Fletcher S, Woods KL. Investigation of the effects of intravenous magnesium sulphate on cardiac rhythm in acute myocardial infarction. Br Heart J. 1994; 71:141-145. 
  • Roffe, C., et al. Randomised, cross-over, placebo controlled trial of magnesium citrate in the treatment of chronic persistent leg cramps. Med Sci Monit. 8(5):CR326-CR330, 2002.
  • Rubinsztein, J., et al. Acute dietary tryptophan depletion impairs maintenance of “affective set” and delayed visual recognition in healthy volunteers. Psychpharmacology. 154: 319-326, 2001.
  • Rude KR. Magnesium metabolism and deficiency. Endocrinol Metab Clin North Am. 22:377-95, 1993.
  • Rude R et al. Magnesium deficiency and osteoporosis: animal and human observations. J Nutr Biochem. 15(12):710-716, 2004.
  • Russo, S, et al. Tryptophan as a link between psychopathology and somatic states. Psychosomatic Medicine. 65: 665-671, 2003.
  • Ryder K et al. Magnesium intake from food and supplements is associated with bone mineral density in healthy older white subjects. J Am Geriatr Soc. 53(11):1875-1880, 2005.
  • Sales CH et al. Influence of magnesium status and magnesium intake on the blood glucose control in patients with type 2 diabetes. Clin Nutr. 30(3):359-64, 2011.
  • Sanjuliani AF et al. Effects of magnesium on blood pressure and intracellular ion levels of Brazilian hypertensive patients. Int J Cardiol. 56:177-83, 1996.
  • Saris NE, Mervaala E, et al. Magnesium: an update on physiological, clinical, and analytical aspects. Clinica Chimica Acta. 294:1-26, 2000.
  • Saris N-EL, Mervaala E, Karppanen H, et al. Magnesium. An update on physiological, clinical and analytical aspects (review). Clinica Chimica Acta. 2000; 294:1-26. 
  • Saris, N.-E. L., et al. Magnesium: an update on physiological, clinical and analytical aspects. Clinica Chimica Acta. 294:1-26, 2000.
  • Sato-Mito N et al. The midpoint of sleep is associated with dietary intake and dietary behavior among young Japanese women. Sleep Med. 12(3):289-94, 2011.
  • Shechter M et al. Effects of oral magnesium therapy on exercise tolerance, exercise-induced chest pain, and quality of life in patients with coronary artery disease. Am J Cardiol. 91:517-21, 2003.
  • Shechter M et al. Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation.102:2353-58, 2000.
  • Shils ME. Magnesium. In: Shils M, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore, MD: Williams and Wilkins; 1999:169-192. 
  • Sinclair, S., et al. Migraine headaches: nutritional, botanical and other alternative approaches. Alternative Medicine Review. 4(2):86-95, 1999.
  • Singh MA. Combined exercise and dietary intervention to optimize body composition in aging. Ann N Y Acad Sci. 1998 Nov 20;854:378-93. 
  • Singh N, Singh PN, Hershman JM. Effect of calcium carbonate on the absorption of levothyroxine. JAMA. 2000; 283:2822-2825. 
  • Sojka JE. Magnesium supplementation and osteoporosis. Nutr Rev. 1995; 53:71-80. Strause L, Saltman P, Glowacki J. The effect of deficiencies of manganese and copper on osteo-induction and on resorption of bone particles in rats. Calcif Tissue Int. 1987; 41:145-150 
  • Song Y et al. Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women. Diabetes Care. 27:59-65, 2004.
  • South, J. L-Tryptophan, nature’s answer to Prozac®. International Antiaging Systems (IAS) Bulletin, 2007. (http://www.antiaginsystems.com/extract/ltrypt.htm)
  • Stendig-Lindberg G et al. Trabecular bone density in a two year controlled trial of peroral magnesium in osteoporosis. Magnes Res. 6:155-63, 1993.
  • Steritei, R. How to get a good night’s sleep with tryptophan. NaturDoctor. 2007. (www.naturdoctor.com/Chapters/Research/Insomnia.pdf)
  • Strause L, Saltman P, Smith KT, et al. Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals. J Nutr. 1994; 124:1060-1064. 
  • Sutherland B, Strong P, King JC. Determining human dietary requirements for boron. Biol Trace Elem Res. 1998 Winter;66(1-3):193-204. 
  • Svetkey LP et al. Effects of dietary patterns on blood pressure: Subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. Arch Intern Med. 159:285-93, 1999.
  • Talbot JR, Guardo P, Seccia S, et al. Calcium bioavailability and parathyroid hormone acute changes after oral intake of dairy and nondairy products in healthy volunteers. Osteoporosis Int. 1999; 10:137-142. 
  • Tanabe, K., et al. Efficacy of oral magnesium administration on decreased exercise tolerance in a state of chronic sleep deprivation. Jpn Circ J. 62(5):341-346, 1998.
  • Tanabe, K., et al. Erythrocyte magnesium and prostaglandin dynamics in chronic sleep deprivation. Clin Cardiol. 20(3):265-268, 1997.
  • Tobian L. Salt and hypertension. Lessons from animal models that relate to human hypertension. Hypertension. 1991; 17:152-158.
  • Tosiello L. Hypomagnesemia and diabetes mellitus. A review of clinical implications. Arch Intern Med. 1998; 156:1143-1148. 
  • Tranquilli AL et al. Calcium, phosphorus and magnesium intakes correlate with bone mineral content in postmenopausal women. Gynecol Endocrinol. 8:55-8, 1994.
  • Trauninger, A., et al. Oral magnesium load test in patients with migraine. Headache. 42(4):114-119, 2002.
  • Tucker KL, Hannan MT, Chen H, Cupples LA, Wilson PW, Kiel DP. Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women. Am J Clin Nutr. 69(4):727-36, 1999.
  • van der Veen, F., et al. Effects of acute tryptophan depletion on mood and facial emotion perception related brain activation and performance in healthy women with and without a family history of depression. Neuropsychopharmacology. 32: 216-224, 2007.
  • Voderholzer, U., et al. Impact of experimentally induced serotonin deficiency by tryptophan depletion on sleep EEG in healthy subjects. Neuropsychopharmacology 18(2): 112-124, 1998.
  • Volpe SL, Taper LJ, Meacham S. The relationship between boron and magnesium status and bone mineral density in the human: a review. Magnes Res. 1993;6:291-296 
  • Vormann J. Magnesium: nutrition and metabolism. Molecular Aspects of Medicine. 24:27-37, 2003.
  • Wang, F., et al. Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial. Headache. 43(6):601-610, 2003.
  • Wargovich MJ, Eng VWS, Newmark HL. Calcium inhibits the damaging and compensatory proliferative effects of fatty acids on mouse colon epithelium. Cancer Lett. 1984; 23:253-258. 
  • Weaver CM, Heaney RP. Calcium. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore, MD: Williams and Wilkins; 1999:141-155. 
  • Wester PO. Magnesium. Am J Clin Nutr. 45:1305-12, 1987.
  • Widman L et al. The dose-dependent reduction in blood pressure through administration of magnesium. A double blind placebo controlled cross-over study. Am J Hypertens. 6:41-5, 1993.
  • Wolf RL, Cauley JA, Baker CE, et al. Factors associated with calcium absorption efficiency in pre- and perimenopausal women. Am J Clin Nutr. 2000; 72:466-471. 
  • Woods KL, Fletcher S. Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet. 1994; 343:816-819. 
  • Woolhouse, M. Migraine and tension headache--a complementary and alternative medicine approach. Aust Fam Physician. 34(8):647-51, 2005. Review.
  • Yu-Yahiro, J. A. Electrolytes and their relationship to normal and abnormal muscle function. Orthop Nurs. 13(5):38-40, 1994.
  • Zemel MB, Shi H, Greer B, et al. Regulation of adiposity by dietary calcium. FASEB J. 2000; 14:1132-1138.

檢視


目前没有對此產品的評價。